UPDATE : Tuesday, June 19, 2018
상단여백
Over 60% of KOSDAQ biotech firms mark falls in Q1 operating profit
More than 60 percent of biotech companies listed on KOSDAQ suffered operati...
by Nam Doo-hyun  |  2018-06-19 11:43
라인
Celltrion completes FDA resubmission for Trastuzumab biosimilar
Celltrion said Monday that it has resubmitted the application to obtain mar...
by Lee Han-soo  |  2018-06-18 17:43
라인
Oral care probiotics research on rise
Domestic microbiome firms such as Bifido are entering the oral care probiot...
by Marian Chu  |  2018-06-18 15:20
라인
SCM, Toolgen to develop new stem cell treatment
SCM Lifescience said Thursday that it has signed a memorandum of understand...
by Lee Han-soo  |  2018-06-15 15:21
라인
NIBEC wins to stem cell regeneration patent
Nano Intelligence Biomedical Engineering Corporation (NIBEC) has acquired a...
by Lee Han-soo  |  2018-06-15 14:43
라인
Nature Cell suspected of manipulating stock prices
The Seoul Southern District Prosecutor's Office recently raided the hea...
by Lee Han-soo  |  2018-06-12 17:54
라인
Celltrion launches new business platform
Celltrion will announce its plan to launch a bio contract development and m...
by Lee Han-soo  |  2018-06-05 17:49
라인
Bio group takes part in US investment conference
Korea Biotechnology Industry Organization (Korea BIO) said Monday that it i...
by Lee Han-soo  |  2018-06-04 16:14
라인
Nature Cell applies for P3 clinical trials
Nature Cell said Friday that Biostar, its stem cell research institution, h...
by Lee Han-soo  |  2018-06-01 15:43
라인
Biosimilars quickly catch up with originals in Korea
Korean biosimilar drugs are quickly chasing original medicines in the domes...
by So Jae-hyeon  |  2018-06-01 15:37
라인
Korean biosimilar makers tap into Japan
Korean manufacturers of biosimilar products are making a foray into Japan, ...
by So Jae-hyeon  |  2018-05-30 15:41
라인
LG Chem launches Enbrel biosimilar in Japan
LG Chem said Wednesday that it has launched Etanercept BS [MA], an Enbrel b...
by Lee Han-soo  |  2018-05-30 14:31
라인
Will biotech stocks rebound on listings in H2?
The biotech industry is paying attention to whether upcoming initial public...
by So Jae-hyeon  |  2018-05-30 11:33
라인
Samsung BioLogics wins FDA nod for drug manufacturing procedure
Samsung BioLogics said Thursday that it has received approval for a drug su...
by Lee Han-soo  |  2018-05-24 15:56
라인
7 Korean biopharma firms dive into biosimilar market
Korea’s “bio fever” is being spurred on by the domestic development of bios...
by Marian Chu  |  2018-05-19 08:19
라인
Celltrion posts ₩245 billion in Q1 sales thanks to biosimilar uptake
Celltrion recorded sales of 245 billion won ($227 million) in the first qua...
by Marian Chu  |  2018-05-16 12:13
라인
Will Korean bio stocks rebound as MSCI includes Celltrion, Viromed, HLB?
Although the stocks of Korean biopharmaceutical companies plummeted followi...
by Marian Chu  |  2018-05-16 11:25
라인
Korean biosimilar companies welcome US pro-biosimilar initiative
Korean biosimilar companies, such as Celltrion welcomed U.S. President Dona...
by Lee Han-soo  |  2018-05-15 17:07
라인
Biotech shares weaken on KONEX, too
As biotech stocks on KOSPI and KOSDAQ have turned downward since mid-April,...
by Nam Doo-hyun  |  2018-05-15 14:02
라인
Large pool of capital available in biotech space: US venture fund expert
American venture capital firms like Mountain Pacific have raised a record a...
by Marian Chu  |  2018-05-11 18:10
여백
여백
여백
Back to Top